non melanotic invasive skin cancer New and Emerging Therapies for Advanced Non-Melanoma Nonmelanoma Skin Cancer | UCSF
Description
Twenty-four weeks of L-carnitine supplementation (2 g/day) was safe in liver cirrhosis patients with CHE
See the ' How to use ' section above
When blood gas analysis is unavailable, a patient who is unwell and meeting the other criteria mentioned above should be suspected of suffering from DKA
